Altimmune Inc (ALT)
6.90
-0.14
(-1.99%)
USD |
NASDAQ |
Apr 18, 16:00
6.86
-0.04
(-0.58%)
After-Hours: 20:00
Altimmune Price to Book Value: 2.517 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 17, 2024 | 2.571 |
April 16, 2024 | 2.747 |
April 15, 2024 | 2.758 |
April 12, 2024 | 2.918 |
April 11, 2024 | 3.068 |
April 10, 2024 | 2.926 |
April 09, 2024 | 3.068 |
April 08, 2024 | 3.145 |
April 05, 2024 | 3.320 |
April 04, 2024 | 3.251 |
April 03, 2024 | 3.393 |
April 02, 2024 | 3.417 |
April 01, 2024 | 3.736 |
March 28, 2024 | 3.718 |
March 27, 2024 | 3.247 |
March 26, 2024 | 3.159 |
March 25, 2024 | 3.116 |
March 22, 2024 | 3.316 |
March 21, 2024 | 3.317 |
March 20, 2024 | 3.401 |
March 19, 2024 | 3.182 |
March 18, 2024 | 3.306 |
March 15, 2024 | 3.590 |
March 14, 2024 | 3.650 |
March 13, 2024 | 3.973 |
Date | Value |
---|---|
March 12, 2024 | 3.958 |
March 11, 2024 | 3.594 |
March 08, 2024 | 3.783 |
March 07, 2024 | 3.652 |
March 06, 2024 | 4.147 |
March 05, 2024 | 4.093 |
March 04, 2024 | 4.024 |
March 01, 2024 | 4.402 |
February 29, 2024 | 4.406 |
February 28, 2024 | 4.836 |
February 27, 2024 | 5.029 |
February 26, 2024 | 4.122 |
February 23, 2024 | 3.35 |
February 22, 2024 | 3.230 |
February 21, 2024 | 2.993 |
February 20, 2024 | 3.059 |
February 16, 2024 | 3.190 |
February 15, 2024 | 3.259 |
February 14, 2024 | 3.281 |
February 13, 2024 | 3.080 |
February 12, 2024 | 3.787 |
February 09, 2024 | 3.802 |
February 08, 2024 | 3.528 |
February 07, 2024 | 3.769 |
February 06, 2024 | 3.874 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4752
Minimum
Nov 19 2019
13.39
Maximum
Jul 20 2020
2.206
Average
1.852
Median
Price to Book Value Benchmarks
Eli Lilly and Co | 65.75 |
Amgen Inc | 22.59 |
Viking Therapeutics Inc | 18.66 |
Precision BioSciences Inc | 3.931 |
Terns Pharmaceuticals Inc | 1.166 |
Price to Book Value Related Metrics
PS Ratio | 861.05 |
Price | 6.90 |
Earnings Yield | -24.24% |
Market Cap | 489.18M |